Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and ...

Co-founder and CEO Jareeporn Jarukornsakul built industrial parks developer WHA from the ground up. Now she's facing the ...

The star of GSK’s Hengrui partnership is the COPD candidate HRS-9821, which will complement the pharma’s respiratory pipeline ...

GSK plc has entered into agreements with China-based biotechnology company Hengrui Pharma to develop up to 12 innovative ...

FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the first half of 2026.

GSK's clinical-stage pipeline is currently focused on oncology, respiratory, immunology and inflammation, and infectious diseases, including HIV, but the ABL deal and others signed in recent ...

Beijing will now require government licenses for any effort to transfer abroad the technologies crucial for producing inexpensive electric cars.

The committee has alleged that it had information the former Pfizer executive, after going to work for British drugmaker GSK, told his colleagues that Pfizer had delayed announcing its Covid ...

GSK is reportedly in negotiations about a $1bn deal to acquire IDRx and its targeted therapy for a form of rare gastrointestinal tumour.

Ghost Factories Are a Warning Sign for Green Manufacturing’s Future Rollbacks of clean-energy credits in Trump’s tax bill add to the sector’s challenges as project cancellations rise.